Trial Profile
A Phase 1/2 Study of RO4929097, An Oral Small Molecule Inhibitor of Gamma-Secretase, in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs RG 4733 (Primary) ; Dexamethasone
- Indications CNS cancer; Haematological malignancies; Leukaemia; Lymphoma; Solid tumours; T-cell leukaemia
- Focus Adverse reactions; Therapeutic Use
- 16 Feb 2017 New trial record